Scilex (SCLX) Stock Insights

SCLX price $2.09 +0.04 +1.95%

Ticker
SCLX
Price
$2.09
Change
+0.04 +1.95%
Market cap ?
$14.70M
P/E ?
-0.04
Forward P/E ?
4.60
Dividend yield ?
0.00%
Beta ?
1.79
Sector
Healthcare
Industry
Drug Manufacturers - General

Financials

2019202020212022202320242025
21033000235600003131700038034000467430005659000030253000

Scilex Holding Company is a biopharmaceutical enterprise that specializes in the development and market introduction of non-opioid therapies designed to alleviate both acute and chronic pain. Its primary marketed offering is ZTlido 1.8%, a topical prescription formulation of lidocaine specifically engineered to mitigate neuropathic discomfort associated with post-herpetic neuralgia, a condition characterized by…

Fair value

SCLX fair value $19.68. Price $2.09. Price is 89% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 10.02M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 1.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 7.03M. Net debt 127.59M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare SCLX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-12-02—-0.08—17.00M
2026-08-14-16.65-0.187.64M16.00M
2026-05-20-4.76-0.218.61M15.00M
2026-04-10-4.60-0.294.79M12.10M
2025-11-14-13.80-13.8010.56M10.56M
2025-08-12-4.62-0.579.90M26.25M
2025-05-14-2.26-4.205.00M5.00M
2025-03-31-0.02-0.1014.90M17.79M
2025-03-17-2.18-0.1014.44M17.87M
2024-08-13-6.29-3.6516.40M16.17M
2024-05-13-9.09-4.2010.90M10.88M
2024-03-11-8.74-7.3413.50M11.43M
2023-11-14-22.03-5.9410.11M11.37M
2023-08-11-5.59—12.60M—
2023-05-12-0.22—10.58M—
2023-03-07-0.16—11.92M—

Dividends

Yield 0.00%. Payout ratio —. Frequency —.

Safety score 24/100 · At risk. Payout ratio is not reported, so this part stays neutral. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-07-03SCLX Stock Acquisition JV LLCSell500.00K——
2026-04-17Ma Stephen HoiBuy650.00K$1.20780.00K
2026-04-17Ji HenrySell650.00K$1.20780.00K
2026-04-16Ji HenryBuy3.25M$1.203.90M
2025-12-30Scilex Holding CoSell9.66M$0.545.21M
2025-12-29Scilex Holding CoSell7.31M$0.664.79M
2025-12-26Scilex Holding CoSell3.69M$0.752.77M
2025-10-08Wu Yue AlexanderBuy20.00K$17.58351.60K
2025-10-08Ma Stephen HoiBuy60.00K$17.581.05M
2025-10-08Chun JayBuy20.00K$17.58351.60K
2025-10-08Ji HenryBuy120.00K$17.582.11M
2025-10-08Followwill DormanBuy20.00K$17.58351.60K
2025-01-21SCLX Stock Acquisition JV LLCSell3.25M$0.00325
2025-01-16SCLX Stock Acquisition JV LLCSell779.37K$0.0078
2025-01-02SCLX Stock Acquisition JV LLCSell5.00M$0.00500
2024-12-18SHAH JAISIMBuy30.00K$0.4613.80K
2024-12-16Chun JayBuy100.00K$0.5050.45K
2024-12-16Followwill DormanBuy100.00K$0.5050.45K
2024-12-16Wu Yue AlexanderBuy100.00K$0.5050.45K
2024-10-31Ji HenryBuy8.89K$0.948.35K
2024-10-29SHAH JAISIMBuy32.00K$0.9931.67K
2024-10-18Followwill DormanBuy1.00K$0.99990
2024-10-18Chun JayBuy5.00K$0.954.75K
2024-10-17Wu Yue AlexanderBuy20.00K$0.9518.99K
2024-10-17Lemus DavidBuy2.00K$0.901.80K
2024-10-17Ji HenryBuy10.00K$0.979.71K
2024-10-16SHAH JAISIMBuy30.00K$0.9929.75K
2024-10-16Ma Stephen HoiBuy6.70K$0.976.50K
2024-08-16Navani AnnuBuy250.00K$1.23307.50K
2024-07-21Navani AnnuOther0——
2024-06-26Followwill DormanSell1.00K$1.371.37K
2024-06-26Followwill DormanBuy1.00K$1.371.37K
2024-06-20Wu Yue AlexanderSell5.00K$1.417.05K
2024-06-20Wu Yue AlexanderBuy5.00K$1.417.05K
2024-06-20Ma Stephen HoiSell2.00K$1.412.82K
2024-06-20Ma Stephen HoiBuy2.00K$1.412.82K
2024-06-20Chun JaySell5.00K$1.417.05K
2024-06-20Chun JayBuy5.00K$1.417.05K
2024-06-20SHAH JAISIMSell14.00K$1.7324.22K
2024-06-20SHAH JAISIMBuy14.00K$1.7324.22K
2024-06-18Ji HenryBuy6.00K$1.418.46K
2024-06-18Ji HenrySell6.00K$1.418.46K
2024-06-14SHAH JAISIMSell33.33K$1.4147.00K
2024-06-14SHAH JAISIMBuy33.33K$1.4147.00K
2024-05-17Ji HenryBuy50.00K$0.8843.98K
2024-05-17Chun JayBuy57.50K$0.9051.64K
2024-05-17SHAH JAISIMBuy56.94K$0.9252.10K
2024-05-17Ma Stephen HoiBuy14.14K$0.8812.44K
2024-05-16SHAH JAISIMBuy83.06K$0.8469.85K
2024-03-15Lemus DavidBuy100.00K$1.37137.00K
2024-03-15Followwill DormanBuy100.00K$1.37137.00K
2023-10-04Ji HenryBuy200.00K$1.41282.00K
2023-10-04SHAH JAISIMBuy200.00K$1.41282.00K
2023-10-04Wu Yue AlexanderBuy250.00K$1.41352.50K
2023-10-04Chun JayBuy250.00K$1.41352.50K
2023-10-04Ma Stephen HoiBuy150.00K$1.41211.50K
2023-09-22Ma Stephen HoiSell0——
2023-09-22Ji HenrySell0——
2023-09-22Ji HenryOther0——
2023-09-22Ji HenryOther0——
2023-09-22Ji HenryOther0——
2023-09-22Ji HenryOther0——
2023-09-22Ji HenrySell232.24K$1.73401.77K
2023-09-22Ji HenrySell9.00M$8.0872.72M
2023-09-22Ji HenrySell1.80M$1.733.11M
2023-09-22SCLX Stock Acquisition JV LLCSell0——
2023-09-22SCLX Stock Acquisition JV LLCSell490.62K$11.505.64M
2023-09-22Wu Yue AlexanderSell404.10K$1.73699.09K
2023-09-22Chun JaySell0——
2023-09-22Ma Stephen HoiSell0——
2023-09-22Ma Stephen HoiSell50.51K$1.7387.39K
2023-09-22Ma Stephen HoiSell294.11K$8.082.38M
2023-09-22Ma Stephen HoiSell55.89K$8.08451.62K
2023-09-22Ma Stephen HoiSell67.35K$1.73116.51K
2023-09-21Sorrento Therapeutics, Inc.Sell60.07M$10.00600.69M
2023-09-21Sorrento Therapeutics, Inc.Sell4.49M$11.5051.64M
2023-03-17Ji HenryBuy2.73K$8.6023.48K
2023-01-19Sorrento Therapeutics, Inc.Sell73.74M——
2023-01-17Followwill DormanBuy250.00K——
2023-01-17Thompson Tommy GBuy250.00K——
2023-01-17Lee Tien-LiBuy250.00K——
2023-01-17Hamill LauraBuy250.00K——
2023-01-17Lemus DavidBuy250.00K——
2023-01-17CZEREPAK ELIZABETHBuy350.00K——
2023-01-17SHAH JAISIMBuy1.70M——
2023-01-17Ji HenryBuy9.00M——
2022-12-02Sorrento Therapeutics, Inc.Buy224.84K$0.3578.85K
2022-11-25Sorrento Therapeutics, Inc.Buy46.17K$0.4420.20K
2022-11-23Sorrento Therapeutics, Inc.Buy442.83K$0.40175.67K
2022-11-22Sorrento Therapeutics, Inc.Buy672.77K$0.23152.05K
2022-11-10Woo Pei WeiOther0——
2022-11-10Myint SteveOther0——
2022-11-10Kaji Suneel GOther0——
2022-11-10Vickers Venture Fund VI Pte LtdSell5.26M——
2022-11-10Vickers Venture Fund VI Pte LtdSell578.16K——
2022-11-10Sorrento Therapeutics, Inc.Buy307.30K——
2022-11-10Sorrento Therapeutics, Inc.Buy2.80M——
2022-11-10Hamill LauraOther———
2022-11-10Hamill LauraOther0——
2022-11-10SHAH JAISIMSell1.57M$1.732.71M

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 71, holders +1 vs prior quarter. Ownership 10.20%.

HolderSharesChangeChange %Value
VANGUARD CAPITAL MANAGEMENT LLC301.29K37.24K+14.10%2.35M
BLACKROCK, INC.109.42K6.62K+6.44%853.45K
VANGUARD FIDUCIARY TRUST CO45.82K6.16K+15.54%357.41K
JACOBS LEVY EQUITY MANAGEMENT, INC41.16K41.16KNew321.07K
STATE STREET CORP35.38K00.00%275.93K
UBS GROUP AG33.38K26.91K+416.02%260.33K
RENAISSANCE TECHNOLOGIES LLC33.06K-3.80K-10.31%257.90K
CITADEL ADVISORS LLC27.50K27.50KNew214.48K
PRICE T ROWE ASSOCIATES INC /MD/20.92K20.92KNew164.00K
ASHTON THOMAS PRIVATE WEALTH, LLC18.48K493+2.74%144.16K
NORTHERN TRUST CORP15.05K14+0.09%117.37K
MORGAN STANLEY4.03K-7.94K-66.32%31.45K
VANGUARD GLOBAL ADVISERS, LLC2.94K00.00%22.91K
OSAIC HOLDINGS, INC.2.34K2.24K+2286.73%18.24K
CREATIVE FINANCIAL DESIGNS INC /ADV1.85K00.00%14.45K
ROYAL BANK OF CANADA1.75K149+9.34%14.00K
JONES FINANCIAL COMPANIES LLLP1.75K1.00K+133.38%12.48K
LARSON FINANCIAL GROUP LLC1.42K1.38K+3278.57%11.07K
METLIFE INVESTMENT MANAGEMENT, LLC1.09K00.00%8.50K
DEUTSCHE BANK AG\80000.00%6.24K
VERSANT CAPITAL MANAGEMENT, INC76100.00%5.94K
IFP ADVISORS, INC57600.00%4.49K
MCF ADVISORS LLC47400.00%3.70K
ACTIVEST WEALTH MANAGEMENT30200.00%2.36K
KLP KAPITALFORVALTNING AS29000.00%2.26K

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Scilex (SCLX) Stock Insights

SCLX$2.09+0.04 +1.95%

$14.70M

Market Cap

-0.04

P/E

4.60

Forward P/E

—

Score

Price History